Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6972)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2014 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in pancreatic cancer. World J Gastroenterol 2014; 20(9): 2321-2334 [PMID: 24605029 DOI: 10.3748/wjg.v20.i9.2321] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i9/2321.htm |
| Number | Citing Articles |
| 1 |
Miguel Muñoz, Rafael Coveñas. Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic Approach. Cancers 2015; 7(3): 1215 doi: 10.3390/cancers7030832
|
| 2 |
M.R. Zielinski, S.A. Karpova, X. Yang, D. Gerashchenko. Substance P and the neurokinin-1 receptor regulate electroencephalogram non-rapid eye movement sleep slow-wave activity locally. Neuroscience 2015; 284: 260 doi: 10.1016/j.neuroscience.2014.08.062
|
| 3 |
Richard E. Kast, Georg Karpel-Massler, Marc-Eric Halatsch. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget 2014; 5(18): 8052 doi: 10.18632/oncotarget.2408
|
| 4 |
Francisco Esteban, Pablo Ramos-García, Miguel Muñoz, Miguel Ángel González-Moles. Substance P and Neurokinin 1 Receptor in Chronic Inflammation and Cancer of the Head and Neck: A Review of the Literature. International Journal of Environmental Research and Public Health 2021; 19(1): 375 doi: 10.3390/ijerph19010375
|
| 5 |
Yang Yang, Xueyan Cao, Yuting Wang, Xinyu Wu, Ping Zhou, Lin Miao, Xueting Deng. Neurokinin‐1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma. Liver International 2024; doi: 10.1111/liv.15904
|
| 6 |
Monireh Davoodian, Nadia Boroumand, Mostafa Mehrabi Bahar, Amir Hosein Jafarian, Mahdi Asadi, Seyed Isaac Hashemy. Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in breast cancer. Molecular Biology Reports 2019; 46(1): 1285 doi: 10.1007/s11033-019-04599-9
|
| 7 |
Christopher T. Lucido, Emily Wynja, Marianna Madeo, Caitlin S. Williamson, Lauren E. Schwartz, Brittney A. Imblum, Ronny Drapkin, Paola D. Vermeer. Innervation of cervical carcinoma is mediated by cancer-derived exosomes. Gynecologic Oncology 2019; 154(1): 228 doi: 10.1016/j.ygyno.2019.04.651
|
| 8 |
Davood Bashash, Ava Safaroghli-Azar, Samaneh Bayati, Elham Razani, Atieh Pourbagheri-Sigaroodi, Arshia Gharehbaghian, Majid Momeny, Maryam Sanjadi, Mostafa Rezaie-Tavirani, Seyed H. Ghaffari. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant. The International Journal of Biochemistry & Cell Biology 2018; 103: 105 doi: 10.1016/j.biocel.2018.08.010
|
| 9 |
Gail Matters, John Harms. Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer. Biomedicines 2018; 6(2): 65 doi: 10.3390/biomedicines6020065
|
| 10 |
O.A. Sergeeva, K. Mazur, A. Kernder, H.L. Haas, R. De Luca. Tachykinins amplify the action of capsaicin on central histaminergic neurons. Peptides 2022; 150: 170729 doi: 10.1016/j.peptides.2021.170729
|
| 11 |
Malihe Golestaneh, Mohsen Firoozrai, Hossein Javid, Seyed Isaac Hashemy. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells. Molecular Biology Reports 2022; 49(6): 4893 doi: 10.1007/s11033-022-07348-7
|
| 12 |
Wei-Sung Li, Kun-Tsung Denzel Lee, Li-Yun Chen, Bang-Jau You, Hong-Zin Lee. Identification of Key Pathways Involved in White Strain of Hypsizygus marmoreus Extracts-Induced Cell Death of Human Hepatoma Hep3B Cells by Next Generation Sequencing. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.888863
|
| 13 |
Maha S. Al-Keilani, Roba Bdeir, Rana I. Elstaty, Mohammad A. Alqudah. Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10633-8
|
| 14 |
Jonathan Kopel, Caezaan Keshvani, Kelly Mitchell, Ted Reid. The Activity of Substance P (SP) on the Corneal Epithelium. Journal of Clinical & Translational Ophthalmology 2023; 1(2): 35 doi: 10.3390/jcto1020006
|
| 15 |
Kun-Tsung Lee, Li-Yun Chen, Wei-Sung Li, Hong-Zin Lee. Transcriptome analysis revealed the role of mTOR and MAPK signaling pathways in the white strain of Hypsizygus marmoreus extracts-induced cell death of human hepatoma Hep3B cells. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1039376
|
| 16 |
Zirong Chen, Yan Fang, Weihong Jiang. Important Cells and Factors from Tumor Microenvironment Participated in Perineural Invasion. Cancers 2023; 15(5): 1360 doi: 10.3390/cancers15051360
|
| 17 |
Yiyi Liang, Huimin Li, Yu Gan, Hong Tu. Shedding Light on the Role of Neurotransmitters in the Microenvironment of Pancreatic Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.688953
|
| 18 |
Qian Shen, Yirun Wang, Nan Zhang, Di Gao, Yudan Liu, Lei Sha. Substance P expresses in intrapancreatic ganglia of the rats. Neuropeptides 2016; 59: 33 doi: 10.1016/j.npep.2016.06.004
|
| 19 |
Yu Zhou, Meng Wang, Yingna Tong, Xiaobin Liu, Lufang Zhang, Dong Dong, Jie Shao, Yunli Zhou. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer. Technology in Cancer Research & Treatment 2019; 18: 153303381987516 doi: 10.1177/1533033819875168
|
| 20 |
Nerves and Pancreatic Cancer: New Insights into a Dangerous Relationship. Cancers 2019; 11(7): 893 doi: 10.3390/cancers11070893
|
| 21 |
Tengfei Ji, Keqiang Ma, Hongsheng Wu, Tiansheng Cao, Fu Wang. A Substance P (SP)/Neurokinin-1 Receptor Axis Promotes Perineural Invasion of Pancreatic Cancer and Is Affected by lncRNA LOC389641. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/5582811
|
| 22 |
Jami L. Saloman, Kathryn M. Albers, Andrew D. Rhim, Brian M. Davis. Can Stopping Nerves, Stop Cancer?. Trends in Neurosciences 2016; 39(12): 880 doi: 10.1016/j.tins.2016.10.002
|
| 23 |
Mahtab Mozafari, Safieh Ebrahimi, Reza Assaran Darban, Seyed Isaac Hashemy. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer. Molecular Biology Reports 2022; 49(2): 1067 doi: 10.1007/s11033-021-06928-3
|
| 24 |
Abbas AlAlikhan, Atefeh Ghahremanloo, Hossein Javid, Safieh Ebrahimi, Seyed Isaac Hashemy. The Effect of Blocking Neurokinin-1 Receptor by Aprepitant on the Inflammatory and Apoptosis Pathways in Human Ovarian Cancer Cells. Cell Biochemistry and Biophysics 2022; 80(4): 819 doi: 10.1007/s12013-022-01100-5
|
| 25 |
Maha S. Al-Keilani, Rana Elstaty, Mohammad A. Alqudah, Ibrahim F. Nassar. The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index. International Journal of Breast Cancer 2022; 2022: 1 doi: 10.1155/2022/4987912
|
| 26 |
Kimberly J. Perry, Paul W. Hamilton, Surabhi Sonam, Ratnakar Singh, Jonathan J. Henry. The role of sensory innervation in cornea‐lens regeneration. Developmental Dynamics 2019; 248(7): 530 doi: 10.1002/dvdy.42
|
| 27 |
Xue‐Ting Deng, Si‐Min Tang, Pei‐Yao Wu, Quan‐Peng Li, Xian‐Xiu Ge, Bo‐Ming Xu, Hui‐Shan Wang, Lin Miao. SP/NK‐1R promotes gallbladder cancer cell proliferation and migration. Journal of Cellular and Molecular Medicine 2019; 23(12): 7961 doi: 10.1111/jcmm.14230
|
| 28 |
Jing Ma, Shifa Yuan, Jianxin Cheng, Shan Kang, Wenhong Zhao, Jie Zhang. Substance P Promotes the Progression of Endometrial Adenocarcinoma. International Journal of Gynecologic Cancer 2016; 26(5): 845 doi: 10.1097/IGC.0000000000000683
|
| 29 |
Chentao Ge, Hemiao Huang, Feiyan Huang, Tianxin Yang, Tengfei Zhang, Hongzhang Wu, Hanwei Zhou, Qi Chen, Yue Shi, Yanfang Sun, Liangjue Liu, Xi Wang, Richard B. Pearson, Yihai Cao, Jian Kang, Caiyun Fu. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload. Proceedings of the National Academy of Sciences 2019; 116(39): 19635 doi: 10.1073/pnas.1908998116
|
| 30 |
Hyojeong Han, Jae-Chul Pyun, Hyein Yoo, Hong Seog Seo, Byung Hwa Jung, Young Sook Yoo, Kyoungja Woo, Min-Jung Kang. Highly Sensitive Immunoassay for the Diagnosis of Acute Myocardial Infarction Using Silica Spheres Encapsulating a Quantum Dot Layer. Analytical Chemistry 2014; 86(20): 10157 doi: 10.1021/ac502412x
|
| 31 |
Silvia Gutierrez, M. Danilo Boada. Neuropeptide-induced modulation of carcinogenesis in a metastatic breast cancer cell line (MDA-MB-231LUC+). Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0707-8
|
| 32 |
Mayuri Mutukuru, T. M. Vijayakumar. Substance P/NK1R Antagonistic Effect of 17-Trifluoromethyl Phenyl Trinor Prostaglandin F2α in Breast Cancer. International Journal of Peptide Research and Therapeutics 2022; 28(3) doi: 10.1007/s10989-022-10410-4
|
| 33 |
Qi Liu, Zhiming Ma, Qian Cao, Hongyu Zhao, Yu Guo, Tongjun Liu, Jiannan Li. Perineural invasion-associated biomarkers for tumor development. Biomedicine & Pharmacotherapy 2022; 155: 113691 doi: 10.1016/j.biopha.2022.113691
|